ForSight Robotics secures $125M to advance its robotic surgery platform, targeting cataract procedures and additional ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

As its director, Manusis outlines the facility’s role in delivering advanced, personalized solutions to improve vision and ...

To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and ...

The center aims to optimize patients' vision with a range of cataract and corneal refractive procedures and minimize reliance ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer ...